Circulating microRNAs as potential marke
โ
Philip J. Starkey Lewis; James Dear; Vivien Platt; Kenneth J. Simpson; Darren G.
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 217 KB
New biomarkers of liver injury are required in the clinic and in preclinical pharmaceutical evaluation. Previous studies demonstrate that two liver-enriched microRNAs (miR-122 and miR-192) are promising biomarkers of acetaminophen-induced acute liver injury (APAP-ALI) in mice. We have examined these